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Abstract: The development of an adequate immune response against pathogens is mediated by molecular interactions be-
tween different cell types. Among them, binding of antigenic peptides to the Major Histocompatibility Complex (MHC) 
molecule expressed on the membrane of antigen presenting cells (APCs), and their subsequent recognition by the T cell 
receptor have been demonstrated to be crucial for developing an adequate immune response. The present review compiles 
computational quantum chemistry studies about the electrostatic potential variations induced on the MHC binding region 
by peptide’s amino acids, carried out with the aim of describing MHC–peptide binding interactions. The global idea is 
that the electrostatic potential can be represented in terms of a series expansion (charge, dipole, quadrupole, hexadecapole, 
etc.) whose three first terms provide a good local approximation to the molecular electrostatic ‘landscape’ and to the 
variations induced on such landscape by targeted modifications on the residues of the antigenic peptide. Studies carried 
out in four MHC class II human allele molecules, which are the most representative alleles of their corresponding haplo-
types, showed that each of these molecules have conserved as well as specific electrostatic characteristics, which can be 
correlated at a good extent with the peptide binding profiles reported experimentally for these molecules. The information 
provided by such characteristics would help increase our knowledge about antigen binding and presentation, and could ul-
timately contribute to developing a logical and rational methodology for designing chemically synthesized, multi-
antigenic, subunit-based vaccines, through the application of quantum chemistry methods. 
Keywords: Computational quantum chemistry, human leukocyte antigens, major histocompatibility complex, molecular elec-
trostatic potentials, vaccines. 
INTRODUCTION 
  In general terms, presentation of antigenic peptides to the 
TCR, a key process for inducing an adequate immune re-
sponse against any foreign antigen, is mainly driven by two 
types of molecules encoded by the MHC genes located on 
the short arm of chromosome 6: (a) Class I molecules 
(MHCI) expressed by all nucleated cells, and (b) Class II 
MHC molecules (MHCII) expressed only by antigen pre-
senting cells (APCs), which include macrophages, dendritic 
cells, Langerhans’ cells, B lymphocytes, monocytes, etc. 
  MHCI and MHCII molecules are structurally and func-
tionally different. MHCI molecules are in charge of present-
ing antigens to T cell receptor to induce a cytotoxic immune 
response mediated by T lymphocytes and are formed by two 
molecular subunits: an  and a  chain (namely 2-
microglobulin). Five domains can be distinguished within 
the  chain: 1, 2 and 3, a transmembrane (shown in yellow 
and orange in Fig. 1A and 1C), and a short intracellular tail, 
to which the 2-microglobulin (shown in green in Fig. 1A 
and 1C) is non-covalently bound. 
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  Conversely, foreign antigens bound to MHCII molecules 
are presented to the T cell receptor and lead to antibody pro-
duction. MHCII molecules are formed by two structural 
units: an invariant  chain containing 1–2 domains (Fig. 1B 
and 1D, in pink) and a shorter polymorphic  chain formed 
by 1–2 domains (Fig. 1B and 1D, in cyan). Both chains are 
anchored to the cell membrane by transmembrane domains 
and short intracellular tails. 
  A binding groove or Peptide Binding Region (PBR) is 
formed at the extracellular end of both types of MHC mole-
cules by two -helices and a platform of  sheets inside 
which the peptide is anchored (Fig. 1A and 1B). Depending 
of the type of MHC molecule, the PBR is formed by differ-
ent domains. In MHCI molecules, the PBR is formed by 1 
and 2 domains (Fig. 1C in orange) and is closed at both 
ends so that only peptides with a constant length of about 8–
10 amino acids can fit inside such groove (Fig. 1C in red). In 
MHCII molecules on the contrary, the PBR is defined by 1 
(Fig. 1D in pink) and 1 domains (Fig. 1D and Fig. 2, in pale 
blue), which form an open groove inside which peptides of 
variable length (between 12–20 amino acids) can be an-
chored (Fig. 1D in red). 
  Five pockets can be distinguished in the PBR of MHCII 






















Fig. (1). Structural and molecular characteristics of Major Histocompatibility Class I and Class II molecules. (A–B) frontal views; (C-D) top 
views, respectively. MHCI molecules (A and C) are formed by two molecular subunits: the  chain (shown in yellow), which contains the 1, 
2 and 3 domains, and the 2-microglobulin (shown in green). In MHCI molecules, the binding groove (orange region in panel C) is formed 
exclusively by  chain residues. MHCII molecules (B and D) are formed by an invariant  chain containing 1–2 domains (shown in pink) 
and a polymorphic  chain formed by 1–2 domains (shown in cyan). In MHCII molecules, the PBR is formed by  and  chain residues. 














Fig. (2). Top view of the binding groove of HLA Class II molecules (HLA-DR1*1501) formed by the  (pink) and  (cyan) chains. (A) 
Position of each Pocket (P1, P4, P6, P7 and P9) in the binding groove. (B) - and -chains amino acids that define each pocket, shown as 
balls according to the following color code: Pocket 1: fuchsia, Pocket 4: dark blue, Pocket 6: orange, Pocket 7: gray, and Pocket 9: green. 748    Mini-Reviews in Medicinal Chemistry, 2010, Vol. 10, No. 8  Agudelo and Patarroyo 
residue is anchored inside a first ‘pocket’ located at the far-
thest portion of the PBR, denoted as Pocket 1, while residues 
towards the peptide’s C-terminus are anchored inside neigh-
bor pockets named Pocket 4, Pocket 6, Pocket 7 and Pocket 
9. 
  In humans, MHC molecules are referred to as Human 
Leukocyte Antigens (HLA). MHCI molecules are encoded 
by the HLA-A, B and C genes for which more than 450 vari-
ants have been reported. Similarly, three large groups of 
gene alleles or isotypes comprising more than 430 variants 
with similar molecular structures exist for human MHCII 
molecules, which are denoted as HLA-DP, DQ and DR, of 
which DR is the most polymorphic region [1]. 
 The   chain of HLA-D Related molecules (HLA-DR) is 
encoded by the first gene of the DR subregion of the HLA 
class II locus, for which it has been named as HLA-DR1*. 
Sixteen alleles have been described for HLA-DR1* denoted 
as HLA-DR1*01–16, which comprise more than 300 vari-
ants and can contain between one (micro-polymorphism) to 
30 amino acid sequence variations. The immune system’s 
ability to respond to the vast diversity of antigens it encoun-
ters during a lifetime depends on the different genetic vari-
ants harbored by an individual, which guarantees an appro-
priate and varied antigen binding/presentation [1]. 
  The first stage, and probably the most important one in 
antigen presentation to induce antibody production, involves 
the recognition of the antigen by any of these HLA-DR1* 
molecules and the perfect fit of its anchoring residues inside 
the binding groove of the PBR, which is stabilized by a net-
work of ~12 hydrogen bonds established between lateral 
chain residues of MHCII molecules and the antigen’s back-
bone residues. Depending on the time that the antigen re-
mains anchored inside the groove of MHCII molecules, the 
TCR would form more stable and appropriate peptide–
MHCII (pMHCII) trimolecular complexes and hence acti-
vate an effective immune response. 
  Since all these steps are fundamental for antigen recogni-
tion, and therefore for the activation of an adequate immune 
response, all these characteristics should be considered for 
developing a logical an rational vaccine development meth-
odology, especially when dealing with multi-antigenic, 
minimal subunit-based, chemically synthesized vaccines. 
  It has been widely shown that peptide binding to the 
MHC groove is mediated by at least two key aspects: (a) 
recognition specificity, and (b) binding strength. Different 
experimental and computational models have been devel-
oped as an approximation to study these two aspects. 
  Experimental models make use of the data gathered by in 
vitro binding assays with purified HLA-DR1* molecules. 
When these molecules are exposed to a panel of peptides, 
only those peptides interacting specifically with purified 
molecules HLA-DR1* molecules are bound. The amino 
acid sequences of bound peptides can be determined by mass 
spectrometry (MS) once they are eluted from the purified 
MHCII molecules. 
  Two types of predictive tools can be constructed based 
on experimental data: (a) binding profiles and (b) mathe-
matical/statistical models. Binding profiles describe which 
amino acids are most frequently found occupying a particu-
lar position in peptides binding to a specific MHCII allele 
and are used for building scoring systems (score matrices 
[2]). These score matrices are in turn used for designing lin-
ear prediction schemes based on the following hypotheses: 
first, that each position within the peptide contributes inde-
pendently to the binding interaction; and second, that resi-
dues located on a given position within a peptide contribute 
equally to peptide binding, even if they belong to different 
peptides. These hypotheses are a good approximation to ex-
plore the peptide binding problem; however, they should be 
used with caution since it has been demonstrated that each 
position within a peptide has a different contribution to the 
peptide’s binding ability, as indicated by assays with trun-
cated peptides, and glycine or alanine analogs [3]. In addi-
tion, an important limitation of this prediction scheme lies on 
the fact that if databases are redundant, the score matrix is 
biased and such bias can result in an over-fitting or under-
fitting of binding values [4], both for false negatives (when 
no binding is predicted but the binding interaction has been 
evidenced in vitro) as well as for false positives (when bind-
ing is predicted but no evidence has been obtain experimen-
tally). 
  To overcome the limitations shown by binding-motif-
based methods, artificial intelligence models have been de-
veloped mainly based on non-linear mathematical/statistical 
models, of which artificial neural networks (NNs) are a clas-
sical example. In these models, the main construction hy-
pothesis results from an initial alignment of peptide se-
quences used in the training of the neural network and se-
quences fed into the model. Due to the large number of pa-
rameters that have to be optimized, this type of models re-
quire of large input sets; an issue that especially in the case 
of MHCII molecules, is problematic since a sufficiently 
large binding dataset is not available. 
  Hidden Markov Models (HMMs) can be also used to 
describe nonlinear complex relationships among datasets. 
Although HMMs should be trained on and feed with large 
datasets, they have the advantage of not requiring a prelimi-
nary alignment of the input sequences. 
  All the aforementioned methods require of large data-
bases and can operate at a maximum proficiency of 80% [4] 
(NNs and HMMs show the best performance). Nevertheless, 
it should be noted that these models have been designed al-
most entirely for MHCI molecules, and that they do not con-
sider the structures of binding peptides and MHC molecules 
as a variable that can affect binding strength and specificity. 
  Structure-based models are constructed based on the in-
formation gathered from the crystal structures of MHC 
molecules loaded with a particular antigenic peptide, and do 
not need to be fed with large amounts of binding data. These 
models can be applied to general ligand–protein interactions 
and compromise less popular protein-structure modeling 
techniques that have higher computational costs. Several 
types of structure-based models have been applied to the 
MHC-peptide problem. One of these models, denoted as 
protein threading or side-chain conformational search, pre-
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structures. In the case of MHC–peptide complexes, the 
method compares the sequence of the query peptide to the 
one of the peptide co-crystallized with a particular Class I or 
Class II molecule [5]. Two aspects are of key importance for 
the structure-based approach: (a) the availability of an ap-
propriate peptide structural template, and (b) the choice of a 
pair-wise potential table. The notion underlying this model is 
that the interaction energy can be expressed as the sum of 
energy-independent pair-wise interactions [6]. 
  Computer-simulated ligand binding or docking is another 
structure-based model widely used in receptor–ligand stud-
ies. This model examines affinities by testing all possible 
binding complexes that result from modifying the ligand’s 
translational, rotational and conformational parameters in 
order to obtain the lowest energy binding complex. How-
ever, due to the combinatorial MHC–peptide problem im-
plicit in this technique, numerous variations have been per-
formed to docking techniques. Molecular dynamics and sta-
tistical mechanical simulations have been employed to 
model receptor–ligand interactions and predict the structure 
of a probable complex between the antigenic peptide and the 
MHC molecule [7]. 
  One of the fields of structure-based models that has 
shown significant development in recent years is molecular 
recognition, an example of such which is the Quantitative 
Structure-Activity Relationship (QSAR) model developed by 
Doytchinova and Flower [8]. Our studies on the modification 
of the electrostatic landscape of MHC pockets are included 
within this field. 
  Our approach focuses on the theoretical study of the in-
teractions between the regions of the HLA-DR1* PBR de-
fined by experimentalists and structuralists as “pockets” and 
the peptide regions more closely interacting with each 
pocket. The model assumes that the interaction of the pep-
tide’s fragments buried inside each pocket is independent 
from the interactions in the remaining pockets. For each 
HLA-DR1* pocket, we have been able to identify which 
peptide amino acids would have a significant interaction, 
obtaining a very good agreement with in vitro results. 
1. ELECTROSTATIC LANDSCAPE AS A TOOL TO 
STUDY PROTEIN INTERACTIONS 
  One the most important problems of biophysical sciences 
is the study of macromolecular interactions between two 
proteins. When molecules are sufficiently close, they influ-
ence each other through forces of electrostatic nature formed 
by the distribution of positive and negative charges, named 
intermolecular forces. The rationale behind studying such 
interactions is to understand the dipoles localized on each of 
the molecules, since these dipole-dipole interactions are the 
main explanation for interactions between biomolecules. 
When there are no permanent dipoles, the attention is fo-
cused on the possibility of having induced dipoles or mo-
mentary dipoles caused by the movement of electrons, which 
would give rise to weak interactions, dispersion forces and 
repulsive interactions. However, dipoles are a fair but crude 
approximation to start with. 
  A spatial distribution of charges (protons and electrons) 
creates an electric scalar field called the Electrostatic Poten-
tial. At large distances, the Electrostatic Potential may be 
expressed as an expansion in powers of 1/r: 
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  The first three terms in the series expansion of the elec-
trostatic potential shown in Equation 1 correspond to the 
monopole or charge (q), dipole (d) and quadrupole (Q), re-
spectively, and are given in polar coordinates (r and ), 
where  is a constant (3.1416...) and 0 is the vacuum permit-
tivity constant. It can be observed that each of the multipoles 
depends on the distribution of the negative charge (electronic 
density, (r)). Such distribution is calculated based on quan-
tum mechanics. 
  Thus, the interaction between molecules is not only a 
matter of interactions between two dipoles, or a dipole and a 
charge, which would reduce the total interaction to just the 
first or two first terms in the former expansion, but it is in-
stead an interaction between two complete fields of charge. 
  Our approach has consisted on using the whole electro-
static potential over both interacting molecules so as to un-
derstand interaction forces not as dipole–dipole interactions, 
but instead as VA(r) vs. VB(r) interactions, where V(r) is the 
whole electrostatic potential of a molecule. The electrostatic 
potential is a scalar field in the space associated with the 
molecule full of heights and valleys, designated as “the elec-
trostatic potential landscape”. Electrostatic potentials may 
be calculated by computational chemistry methods at the 
same level of accuracy of the wave function for any particu-
lar level of theory. 
  Nevertheless, computing the energy of interaction be-
tween two charge distributions remains a difficult task and 
for molecules as large as MHC molecules and peptides, it is 
still a far more elaborated problem. We have focused on 
qualitatively describing the variations induced on the elec-
trostatic potential landscape of each interacting molecule 
when the second molecule is in its vicinity. These qualitative 
variations allowed us to classify pockets and occupying pep-
tides according to the main effects induced on the electro-
static landscape. 
1.1. Understanding Changes in the Electrostatic Land-
scape: The Multipolar Approach 
  This model is based on charge variations determined by 
means of quantum mechanical calculations. By considering 
charges as punctual charges (q), the different multipolar 
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follows: first, the value of Mulliken’s atomic partial charges 
[9] is calculated using the Hartree-Fock (HF) method im-
plemented in Gaussian [10]. These calculations are per-
formed for each pocket by systematically changing the occu-
pying amino acid [11] by each of the 20 possibilities. Since 
each replacement is expected to induce variations on the 
pocket’s electrostatic landscape, it is reasonable to take into 
account the electrostatic changes produced in the peptide’s 
lateral chains. 
  In consequence, the charge of a residue can be estimated 
based on the net partial charges of each residue’s lateral 
chain atoms as follows: 
 
qi
aa =q side chain atoms   
  The magnitude of the dipole and quadrupole of each resi-
due is also estimated based on the charges of the atoms that 
composed each lateral chain, considering the  carbon as the 
coordinate origin for each dipole vector and quadrupole ten-
sor: 
 
x´= x  xC  
 
y´= y  yC  
 
z´= z  zC  
  Calculating the dipole moment as: 
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and the quadrupole moment as: 
Qmn
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  Given that the charge, dipole and quadrupole have differ-
ent orders of magnitude, they are normalized before being 
compared according to the following expression: 
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  Since the aim is to identity the main electrostatic poten-
tial differences that occur at the interaction between peptides 
and MHC molecules, we proposed the descriptors S
aa and 
 DifTot
aa  which are based on normalized multipolar moments: 
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where Si
aa  is calculated for each pocket’s amino acid (i). 
This descriptor allows quantifying the electrostatic variations 
induced on the amino acids that define an occupied pocket 
(o) when the amino acid (aa) occupying such pocket is sys-
tematically replaced, taking the electrostatic landscape of the 
empty pocket (e) as a reference. The  DifTot
aa  descriptor is cal-
culated for each pocket according to the aa occupying it and 
allows sensing global variations on the pocket’s electrostatic 
behavior. 
1.2. Graphs of Electrostatic Potential 
  This model has been applied to four MHC class II human 
molecules (HLA-DR1* alleles) for which a crystallographic 
model is available in the PDB protein data bank: HLA-
DR1*0101 (PDB: 1dlh), HLA-DR1*0401 (PDB: 1j8h and 
2seb), HLA-DR1*0301 (PDB: 1a6a) and HLA-DR1*1501 












Fig. (3). (A) Global electrostatic variations ( DifTot
aa ) on HLA-DR1*0101’s pockets when being occupied by each of the 20 possible amino 
acids. (B) Same global electrostatic variations shown in panel A but without including charged occupying amino acids (lysine, histidine, 







































Fig. (4). Electrostatic variations (S
aa) on each of the amino acids that define a given pocket induced by each of the 20 possible occupying 
amino acids. The following cases are shown for Pockets 1, 4 and 6 defined in the HLA-DR1*0101-HA (left panel) and HLA-DR1*0401-
Col II molecular complexes (right panels): (A) general or global variation (anchorage), (B) general variations (anchorage) mixed with spe-
cific variations (recognition) and (C) specific variations (recognition). See text for more detail. 752    Mini-Reviews in Medicinal Chemistry, 2010, Vol. 10, No. 8  Agudelo and Patarroyo 
  One of the first and most important results is related to 
the global electrostatic modifications ( DifTot
aa ) induced on 
each pocket. As can be observed in Fig. (3A) and Fig. (3B), 
there is a large average variation on the electrostatic land-
scape of the HLA-DR1*0101 molecule’s Pocket 1 (P1) 
when comparing the occupied pocket and the empty pocket, 
while such variation is lower and more diffused on the other 
four pockets (P4, P6, P7 and P9). It is expected for the elec-
trostatic landscape to change abruptly when the occupying 
amino acid is charged, as shown in Fig. (3A) for Lys, His, 
Arg, Asp, Glu. Nevertheless, milder variations are also ob-
served when the occupying amino acid is not charged, as 
indicated by the  DifTot
aa  variance shown in Fig. (3B); which 
despite not being notoriously large, is not zero in any case. 
These small variations could explain the binding selectivity 
shown by certain amino acids. 
  An analysis of the electrostatic behavior on each of the 
amino acids that define a particular pocket when the pocket 
is occupied by each of the different amino acids is shown in 
Fig. (4). The graph shows the average S
aa on each pocket’s 
amino acid with its corresponding variations indicated by 
length of the whisker. Three possible cases are identified in 
this graph: (a) a general variation of S
aa induced by the pres-
ence of an occupying amino acid regardless of its identity 
(Pocket 1’s amino acids showing such behavior are indicated 
by red arrows in Fig. 4A); (b) a large electrostatic variation 
exclusively associated to the identity of the occupying pep-
Table 1.  Amino Acids that Define Each of the Pockets in the Four Alleles Here Analyzed. aa = Polymorphic Positions, aa = Recog-
nition Amino Acids, aa = Anchorage Amino Acids and aa = Occupying Amino Acids. 
Pocket Allele   chain   chain  Peptide fragment 
DR1*0101  I7 F24 F26 F32 W43 A52 S53 F54 
E55 
H81 Y83 V85 G86 F89 V91  P306 K307 X308 
V309 
DR1*1501  I7 F24 F26 F32 W43 A52 S53 F54 
E55 
H81 Y83 V85 G86 F89 V91  E85 N86 P87 V88 
X89 H90 
DR1*0301  I7 F24 F26 F32 W43 A52 S53 F54 
E55 
H81 Y83 V85 V86 F89 V91  P87 V88 S89 K90 
X91 R92 
1 
DR1*0401  I7 F24 F26 F32 W43 A52 S53 F54 
E55 
H81 Y83 V85 G86 F89 V91  A1168 Y1169 
X1170 R1171 
DR1*0101  Q9 A10 E11 F24 N62  F13 E14 C15 L26 L27 E28 F40 Q70 R71 R72 A73 
A74 Y78 C79 
K310 X311 N312 
DR1*1501  Q9 A10 E11 F24 N62  R13 E14 C15 F26 L27 D28 F40 Q70 A71 R72 A73 
A74 Y78 C79 
F91 X92 K93 
DR1*0301  Q9 A10 E11 F24 N62  S13 E14 C15 Y26 L27 D28 F40 Q70 K71 R72 G73 
R74 Y78 C79 
M93 X94 T95 
4 
DR1*0401  Q9 A10 E11 F24 N62  H13 E14 C15 F26 L27 D28 F40 Q70 K71 R72 A73 
A74 Y78 C79 
A1172 X1173 
A1174 
DR1*0101  Q9 A10 E11 A61 N62 I63 A64 
V65 D66 N69 
W9 Q10 L11 K12 F13 E28 R29 C30 R71  N312 X313 L314 
DR1*1501  Q9 A10 E11 A61 N62 I63 A64 
V65 D66 N69 
W9 Q10 P11 K12 R13 D28 R29 Y30 A71  K93 X94 I95 
DR1*0301  Q9 A10 E11 A61 N62 I63 A64 
V65 D66 N69 
E9 Y10 S11 T12 S13 D28 R29 Y30 K71  T95 X96 L97 
6 
DR1*0401  Q9 A10 E11 A61 N62 I63 A64 
V65 D66 N69 
E9 Q10 V11 K12 H13 D28 R29 Y30 K71  A1174 X1175 
A1176 
DR1*0101  V65 N69  L11 F13 E28 C30 V38 Y47 W61 Q64 L67 R71  T313 X314 K315 
DR1*1501 V65  N69  P11 R13 D28 Y30 V38 F47 W61 Q64 I67 A71  N94 X95 V96 
DR1*0301 V65  N69  S11 S13 D28 Y30 V38 F47 W61 Q64 L67 K71  P96 X97 L98 
7 
DR1*0401 V65  N69  V11 H13 D28 Y30 V38 Y47 W61 Q64 L67 K71  A1175 X1176 
G1177 
DR1*0101  A68 N69 L70 E71 I72 M73 R76  W9 C30 S37 V38 D57 Y60 W61  K315 X316 A317 
T318 
DR1*1501  A68 N69 L70 E71 I72 M73 R76  W9 Y30 S37 V38 D57 Y60 W61  V96 X97 P98 R99 
DR1*0301  A68 N69 L70 E71 I72 M73 R76  E9 Y30 N37 V38 D57 Y60 W61  L98 X99 Q100 
A101 
9 
DR1*0401  A68 N69 L70 E71 I72 M73 R76  E9 Y30 Y37 V38 D57 Y60 W61  G1177 X1178 
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tide (measured by length of variation bars and indicated by 
blue arrows in Fig. (4C) corresponding to Pocket 6); and (c) 
a mixed behavior showing a general electrostatic variation 
irrespectively of the presence of an amino acid inside the 
pocket, and notable variations related to the identity of the 
occupying amino acid (blue-red arrows in Fig. (4B) corre-
sponding to Pocket 4). 
  These effects can be correlated with the binding capacity 
shown by the peptide’s residues buried inside the binding 
groove, which can be analyzed in two different ways: (a) 
nondifferential or nonspecific binding amino acids denoted 
as anchorage amino acids (on which when the electrostatic 
potential varies between an empty and an occupied pocket), 
and (b) differential or specific binding amino acids (on 
which the electrostatic potential varies exclusively as a result 
of the identity of the amino acid occupying the pocket). 
There are also combined effects caused by entry of a peptide 
portion and the identity of each particular amino acid, and 
are designated as anchorage-recognition amino acids (Fig. 
4B). Therefore, this methodology allows identifying the role 
played by the residues that define a given pocket and to clas-
sify such residues according to the electrostatic potential 
changes induced on them. A summary of each of the studied 
alleles is shown in Table 1, where anchoring amino acids are 
shown in red, recognition amino acids in blue and anchor-
age-recognition amino acids in red-blue. 
  The performance of the model was evaluated by contrast-
ing our findings with experimental data. For such purpose, 
we chose as the prototype occupying amino acid the pep-
tide’s amino acid that was identified as being buried inside a 
particular pocket when the antigenic peptide was co-
crystallized an MHCII allele. Such ‘best-fit case’ obtained 
for a particular pocket of a given HLA-DR1* allele by X-
ray crystallography was denoted as the ideal amino acid. 
Electrostatic variations induced by the ideal amino acid and 
by other occupying amino acids were compared under the 
hypothesis that those occupying amino acids that induce 
electrostatic landscape variations comparable to the ones 
induced by the ideal amino acid should have similar binding 
characteristics. 
  In the case of the HLA-DR1*0101-HA’s Pocket 1 (Fig. 
5A), which is the largest and most important binding pocket 
in HLA-DR1* alleles, we found that the ideal occupying 
amino acid was Tyr (for more clarity, peptide amino acids 
are written in three-letter code and MHCII residues in one-
letter hereafter). Other important occupying amino acids are 
Phe and Trp (all of which correspond to aromatic amino ac-
ids). Bearing in mind that the -chain G86V dimorphism is 
located on Pocket 1 and that the allele herein analyzed har-
bors the 86G variant, its reasonable to hypothesize that other 
amino acids having smaller masses like leucine, isoleucine, 
methionine and cysteine can also fit inside this pocket re-
gardless of residue being present in position 86 (valine or 
glycine). 
  By the same token, Pocket 6 (Fig. 5B) is the most rele-
vant pocket in HLA-DR1*0101 molecules since it is the 
smallest one. Our data for this pocket was contrasted to ex-
perimental data reporting Ala as the ideal occupying amino 
acid. Other ideal amino acids that have been reported include 
Gly, Ser, Thr and Pro. In the present work, the amino acids 
presenting a behavior more similar to the one shown by Ala 
were Pro, Gly, Thr and Ser (Fig. 7); totally agreeing with 
experimentally obtained results [18]. 
  It was difficult to optimize the side-chain geometry of the 
occupying amino acid for Pocket 6, mainly because there are 
two conserved amino acids in all Class II molecules within 
this pocket (11E and 66D), which are very close to each 
other and whose interactions are stabilized by a network of 
hydrogen bonds. This situation prevents the interaction of 
this pocket with charged residues or with residues having 
long side chains, as it has been also found experimentally for 
most Class II alleles. 
  As another example of critical binding pockets, we can 
mention HLA-DR1*1501 (Fig. 6). For Pocket 4, we found 
that Phe, Tyr, Trp, Ile, Cys, Ala, Gln, Leu and Val induce 
electrostatic variations similar to the ones induced by the 
ideal occupying amino acid Phe, which is in complete 
agreement with almost all the amino acids that have been 
reported to be binding motifs for this pocket [18], and to 
have a large affinity for this allele’s pocket (Phe, Tyr, Leu, 
Ile, Val and Ala). Large polar residues such as Lys or His, or 
short as Asp, introduce dramatic changes in the electrostatic 
landscape, as seen in Fig. (6A). Therefore, these amino acids 
are not likely to fit inside this pocket. 
  In Pocket 9, there is a genetic polymorphism where those 
alleles carrying the 57D variant, which establishes a salt 
bridge with 76R, have been found to bind apolar residues 
such as Leu, Ile, Val, Ala, Ser, Thr and Cys in experimental 
assays; this being in complete agreement with our results in 
the underlined amino acids. Those alleles carrying the 57 
variant (replaced by A, S or V) bind charged residues like 
Glu, Asp and Gln in HLA-DR1*0405, or Arg and Lys in 
HLA-DR5*0101. 
  The mild and large electrostatic changes produced on 
HLA-DR1*0101 and HLA-DR1*1501 pockets can be 
observed in the MSMS surfaces [19] shown in Figs. (5 and 
6), respectively. A visual inspection based solely on these 
maps is diffuse, whereas the descriptors herein proposed 
allow ‘quantifying’ changes on the electrostatic landscape 
and therefore to make a more precise analysis. 
 Fig.  (7) shows the high correlation existing between oc-
cupying amino acids being identified experimentally for 
each of the HLA-DR1*0101 molecule’s pockets and the 
ones identified by our model, which leads us to conclude that 
the hypothesis herein postulated regarding electrostatic land-
scape variations allows explaining and helps understanding 
the binding properties of the peptide’s residues buried inside 
the groove of MHCII molecules. 
2. GLOBAL ANALYSIS 
  When the results obtained for the four alleles discussed in 
this review are examined, common and particular features 
are observed among them. The average values of the  DifTot
aa  
descriptor for each studied allele show that the largest elec-
trostatic changes occur on Pocket 1. This could be correlated 




































Fig. (5). (Inner plot) Comparison of molecular electrostatic potential (MEP) changes expressed in terms of  DifTot
aa  with respect to the ideal 
amino acids: tyrosine for Pocket 1 (A), and alanine for Pocket 6 (B). (Around) Electrostatic potential on the Michel Sanner’s Molecular Sur-
faces (MSMS [19, 20]) of Pockets, obtained by changing the identity of the occupying amino acid (encircled in red on the inner plot). Re-
gions of negative electrostatic potential are shown in red, near zero in white, and positive in blue. Note the different degrees of MEP variation 
induced by some peptide amino acids and how such variation is quantified by the  DifTot







































Fig. (6). (Inner plot) Comparison of MEP changes expressed in terms of  DifTot
aa  with respect to the ideal amino acid: Phenylalanine for 
Pocket 4 (A), and threonine for Pocket 9 (B) (see details in Fig. 5’s caption). 756    Mini-Reviews in Medicinal Chemistry, 2010, Vol. 10, No. 8  Agudelo and Patarroyo 
the peptide’s N-terminus, a key factor in the binding of anti-
genic peptides to the PBR. This feature is largely conserved 
among all HLA-1* alleles, as shown by the fact that only 
the  G86V dimorphism is found for this pocket, but data 
shown in Table 1 indicate that 55E and 81H are also im-
portant for peptide binding. An example of the  DifTot
aa  elec-
trostatic variation on Pocket 1 is shown in Fig. (4A), where it 
can be observed that the occupying amino acid affects each 
of the various amino acids that define this pocket in different 
ways and magnitude. Predominantly, 55E and 81H are the 
most largely affected amino acids (Fig. 4A), and this pattern 
is conserved among all Class II molecules studied to date 
[21, 22]. In particular and in support of our data, it is known 
that this latter amino acid is involved in the formation of a 
hydrogen bond with the peptide’s backbone. 
 The   DifTot
aa  variation in the other pockets changes de-
pending on the allele and peptide being analyzed. As ob-
served in Table 1, other amino acids located in different 
pockets are also relevant for the peptide’s anchorage, such as 
74R in DR1*0301,  62N in DR1*0101,  71E in 
DR1*1501 / DR1*0401, and finally 71 in Pocket 6. 
  On the other hand, recognition amino acids (i.e. those 
that are sensitive to the identity of the occupying amino acid) 
and amino acids corresponding to polymorphic positions can 
be also distinguished in Table 1 (highlighted in blue and 
gray, respectively). Initially, it would be expected for poly-
morphic positions to be the only ones responsible for the 
pocket’s specificity for a particular occupying amino acid, 
but the analysis indicates that some conserved positions play 
also an important role in sensing variations in the identity of 
the occupying amino acid. The most notable case is shown in 
Pocket 1, where amino acids corresponding to conserved 
positions such as 32F, 43W and 85V are important for 
peptide recognition. Other important peptide recognition 
amino acids include the Pocket 4’s 13F, 26L and 74 po-
lymorphic positions, Pocket 6’s 11 and 71 variants, and 
the Pocket 9’s 57D semi-conserved position. 
3. CONCLUDING REMARKS 
  The results described in this mini-review highlight the 
plausibility of using ab initio methods to study biomolecular 
systems. Two methods have been commonly used for esti-
mating molecular electrostatic properties: methods based on 
the Poisson-Boltzmann equation (PBE) and methods based 
on the electron density. In the first group of methods, it is 
necessary to assign a value to the atomic charges a priori 
(Field Force), which would remain constant with respect to 
different configurations that the molecule can adopt (a hy-
pothesis that is not necessarily true). On the contrary, a ma-
jor advantage of the second group of methods is that the 
value of the partial atomic charges is deduced by partitioning 
the wave function or density function (electronic popula-
tion), and therefore the charges vary as the molecular con-
figuration varies. Accordingly, ab initio methods take into 
account the electronic distribution and its variability; a 
highly desirable characteristic in the study of molecular in-
teractions between biomolecules given that, as it is well-
known, inter-and intra electrostatic forces involved in such 
interactions are mainly weak forces that result from the dis-
persion of the electric charge distribution [28,29]. 
  The molecular descriptors proposed based on the multi-
polar expansion, which aims to describe the electrostatic 
landscape outlined by the molecular interaction, are of great 
value for evaluating the postulated hypothesis of similarity 
(similar electrostatic landscapes are associated to similar 
molecular activities) and addressing the complex problem of 
receptor–ligand complexes. This approach has shown good 
correlation with the experimental results of peptide binding 
to MHCII molecules [18], and has allowed identifying the 
key residues involved in this molecular interactions, thus 
showing great utility for understanding and elucidating the 
mechanisms involved in the process of receptor-ligand inter-
action as well as and for designing subsequent mutagenesis, 
bio-informatics and immunogenicity analysis of the key 
amino acid residues (both for the ligand and the receptor) 
among different MHCII alleles. 
  In the light of the promising results obtained so far for 
the peptide–MHCII binding problem, it would worth to keep 
on working with this approach and widen the electrostatic 
landscape model. For instance, much of the effort invested in 
calculating these type of biomolecular systems ab initio is 
not productive because the multipolar expansion series is 
restricted to the first three terms and therefore terms that 



















Fig. (7). Comparison between theoretical data estimated based on 
the electrostatic landscape approach and experimental data reported 
as a logo plot [18] for the HLA-DR1*0101 allele. In the theoreti-
cal profile (upper plot), amino acid agreements are shown in red, 
while non-agreements are shown in black. Quantum Chemical Analysis of MHC-Peptide Interactions  Mini-Reviews in Medicinal Chemistry, 2010, Vol. 10, No. 8    757 
charge densities (non-point charges) are left out; moreover, 
there is no way of knowing how much information ne-
glected. It would be more appropriate to work with the full 
scalar field defined by the electrostatic potential function, 
but that would require the use of mathematical functions 
with special properties (e.g. metric functions) to define mo-
lecular descriptors that could measure differences between 
such mathematical “objects” [30]. Moreover, it would be 
desirable to increase the level of ab initio single-point calcu-
lations, and to complementarily include Docking and Mo-
lecular Dynamics approaches to determine the configuration 
of the peptide amino acids that are anchored in MHCII pock-
ets. Our current efforts focus on this purpose. 
  Research conducted in the search of a rational and logical 
vaccine development methodology has led us to identify 
some emerging principles for designing minimal subunit-
based chemically synthesized vaccines [23]. One of these 
principles consists in modifying the critical host-cell binding 
residues of a candidate vaccine peptide specifically so as to 
improve its presentation to the TCR, bearing in mind that 
changes performed on the amino acid sequence result in 
structural and functional modifications due to the intrinsic 
structural complexity and degrees of freedom that relatively 
short peptides have (15–20 residues) [24-26]. This complex 
task would be greatly aided by theoretical models validated 
based on experimentally reported binding motifs and binding 
registers capable of describing the TCR–pMHCII molecular 
interaction system with good degree of accuracy. In this 
sense, studies such as the one reviewed in the present work 
are of key importance as they allow determining which 
amino acids can be replaced without altering the peptide’s 
overall binding characteristics but instead enhancing its 
binding properties. 
  Molecular recognition and molecular modeling are not 
only promising and developing areas of biochemical sci-
ences but also of theoretical and computational chemistry. 
We are certain that the integration of these types of models, 
complemented with the results of HLA-DR1* molecules 
binding, T-cell proliferation and immunization assays, which 
we are currently performing in Aotus monkeys [23], will 
allow us to move forward in our endeavor to define theoreti-
cal principles for synthetic vaccine development. 
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